Latest News & Updates
Breaking News
3 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Laurus Labs posts 23% revenue rise on CDMO manufacturing scale-up
Laurus Labs reports 23% FY26 revenue growth and Rs 279 crore Q4 profit, driven by CDMO expansion and advanced manufacturing scale-up.
Pharma Now Editorial Team
Ajanta Pharma's 49% US generics surge signals mid-tier scaling shift
Ajanta Pharma's Q4 FY26 revenue rose 21% to Rs 1,422 crore, with US generics up 49%, a benchmark for mid-tier Indian manufacturers scaling FDA-regulated output.
Pharma Now Editorial Team
Five FDA observations at Biocon Bengaluru site test biosimilar approval path
FDA issued five procedural observations after a pre-license inspection at Biocon Biologics' Bengaluru site, placing the company's biosimilar BLA timeline under review.
Pharma Now Editorial Team
SB27 PK data sharpens the pembrolizumab biosimilar race
Samsung Bioepis' SB27 met PK bioequivalence endpoints in a Phase 1 NSCLC study, advancing the pembrolizumab biosimilar programme toward confirmatory trials.
Pharma Now Editorial Team
